Showing results (351-360 of 601) with videos related to

Sort By:
Pageof 61
Journal of Neurology|August 19, 2018
Moyamoya angiopathy: early postoperative course within 3 months after STA-MCA-bypass surgery in Europe-a retrospective analysis of 64 proceduresMarkus Kraemer, Jasmin Sassen, Rusen Karakaya, et al.
Journal of the Peripheral Nervous System : JPNS|March 10, 2022
Analysis of relapse by inflammatory Rasch-built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathyIngemar S J Merkies, Ivo N van Schaik, Vera Bril, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 17, 2010
CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virusClemens Warnke, Vsevolod Smolianov, Thomas Dehmel, et al.
Muscle & Nerve|March 3, 2015
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapseRussell L Chin, Chunqin Deng, Vera Bril, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 3, 2020
NK cell markers predict the efficacy of IV immunoglobulins in CIDPAnne K Mausberg, Maximilian K Heininger, Gerd Meyer Zu Horste, et al.
BMC Neurology|September 5, 2020
Retinal layers and visual conductivity changes in a case series of microangiopathic ischemic stroke patientsJohn-Ih Lee, Lena Gemerzki, Margit Weise, et al.
JAMA Neurology|April 20, 2013
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responsesBernd C Kieseier, Olaf Stüve, Thomas Dehmel, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2015
Oligodendroglial maturation is dependent on intracellular protein shuttlingPeter Göttle, Jennifer K Sabo, André Heinen, et al.
Multiple Sclerosis and Related Disorders|February 18, 2025
Cognitive effects of ocrelizumab vs interferon β-1a in relapsing multiple sclerosis: A post hoc analysis of the OPERA I/II trialsRalph Hb Benedict, Ludwig Kappos, Aaron Miller, et al.
Archives of Neurology|August 12, 2009
Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosisSabine Cepok, Herbert Schreiber, Steve Hoffmann, et al.
Pageof 61